In this episode of Inside the Emerging Growth Markets, Joseph Lucosky continues the conversation on the resurgence of direct listings, this time taking a closer look at how these transactions are being structured in today’s emerging growth markets.

While direct listings have traditionally been associated with companies that do not need to raise capital, the modern approach looks very different. Joseph explains how companies are raising capital around the listing process and how financing, investor protections, and exchange requirements must work together as part of a broader transaction strategy.

In this episode, Joseph covers:

• How companies are raising capital around the direct listing process
• Why convertible preferred stock has become a popular financing structure
• How escrow arrangements and milestones can balance the needs of companies and investors
• The role exchange requirements play in shaping financing terms
• Why a successful direct listing requires careful coordination long before listing day

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].

In this episode of Inside the Emerging Growth Markets, Joseph Lucosky takes listeners Inside Washington following the latest meeting of the SEC’s Small Business Capital Formation Advisory Committee and examines what he believes could be a once-in-a-generation opportunity to modernize the public markets for smaller and emerging growth companies.

From expanding access to registered offerings to simplifying the regulatory framework for public companies and rethinking how often companies are required to report, Washington is asking fundamental questions about the costs and complexities of being public. Joseph breaks down the proposals currently under consideration, the debate happening around them, and what these potential changes could mean for companies navigating the public markets today.

In this episode, Joseph covers:

• How proposed S-3 reforms could significantly expand access to capital for smaller public companies
• Why the treatment of OTC companies has become an important part of the capital formation debate
• What proposed filer-status reforms could mean for the majority of public companies
• The debate over quarterly versus semiannual reporting and why optionality matters
• How Washington is balancing capital formation, regulatory burden, transparency and investor protection

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].

In this episode of Inside the Emerging Growth Markets, Joseph Lucosky explores why direct listings are making a comeback and how they fit into a broader shift in the way emerging growth companies are approaching the public markets.

As the traditional IPO market has become increasingly selective, boards and management teams are looking more closely at alternative pathways to going public. But today's direct listings look very different from the transactions that first brought the structure into the spotlight. Joseph breaks down how the market has evolved, why the traditional direct listing playbook is outdated, and what companies should consider when determining whether this pathway is right for them.

In this episode, Joseph covers:

• Why direct listings are gaining momentum in the emerging growth markets
• How today's direct listings differ from the traditional model
• What makes a company a strong candidate for a direct listing
• Why private financing and valuation decisions can impact a future listing
• How boards can evaluate the right pathway to the public markets

Direct listings may not be right for every company, and they are unlikely to replace the traditional IPO. But as alternative pathways continue to play a larger role in today's market, understanding the options available, and choosing the structure that fits the company rather than forcing the company into a transaction, has become increasingly important.

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].

In this special report episode of Inside the Emerging Growth Markets, Joseph Lucosky breaks down one of the most significant regulatory developments affecting the emerging growth markets this year: the SEC's approval, and subsequent stay, of Nasdaq's proposed $5 million market value continued listing rule. Over the course of just eight days, the conversation shifted from implementation to uncertainty, leaving companies, boards, and advisors asking the same question: What's next?

Joseph explains what actually happened during those eight days, why the rule was paused, and why the stay should not be mistaken for a final decision on the proposal itself. Separating the headlines from the regulatory process, he discusses why public companies should continue preparing despite the uncertainty and why periods of regulatory change often create opportunities for proactive leadership.

In this episode, Joseph covers:

• What happened during the eight days between the rule's approval and stay
• Why the SEC paused implementation of Nasdaq's proposed $5 million rule
• The procedural review process and what it means for public companies
• Why boards should continue evaluating financing and strategic alternatives
• How companies can prepare while regulatory uncertainty continues

Whether the rule ultimately moves forward or not, the challenges facing emerging growth companies remain the same. Joseph shares why preparation, strategic planning, and decisive leadership continue to matter, regardless of how the regulatory process unfolds.

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].

In this episode of Inside the Emerging Growth Markets, Joseph Lucosky explores the next evolution of digital asset treasury companies and why many boards are beginning to shift their focus from accumulating digital assets to creating long-term shareholder value.

As the market has matured, many digital asset treasury companies are entering a new phase of strategic decision-making. Joseph explains why today's management teams and boards must begin thinking beyond digital asset accumulation and instead evaluate the highest and best use of their public company platforms. Drawing parallels to SPACs, not from a legal standpoint, but as a strategic framework, Joseph offers a new perspective on how many digital asset treasury companies may approach their next chapter. He also discusses how acquisitions, reverse mergers, business pivots, and disciplined capital allocation could play a role in that evolution.

In this episode, Joseph covers:

• Why digital asset treasury companies are entering a new phase of growth
• What he means by "mini SPACs" and the strategic opportunities they present
• Why boards should shift from treasury management to capital allocation
• How acquisitions, reverse mergers, and business pivots may shape the next chapter
• The leadership traits that will separate successful companies from those that stand still

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].

In this episode of Inside the Emerging Growth Markets, Joseph Lucosky breaks down what the Q2 2026 data is really telling us about today's emerging growth markets and why signs of improvement should not be mistaken for a full market recovery.

While deal activity improved modestly from the first quarter, the market remains highly selective. Joseph analyzes the latest IPO, direct listing, uplisting, and cross-listing data to explain where capital is flowing, how exchange behavior continues to evolve under Nasdaq's discretionary review framework, and why pathway selection has become one of the most important strategic decisions companies can make. Rather than focusing solely on transaction volume, he explores what the underlying trends reveal about the direction of the market and the opportunities that still exist for well-prepared issuers.

In this episode, Joseph covers:

• What the Q2 2026 data reveals about today's market
• Why IPO activity is improving—but remains highly selective
• How direct listings and alternative pathways continue to gain traction
• What the latest exchange and issuer trends signal for founders and advisors
• Why pathway selection has become more important than ever

As the emerging growth markets continue to adapt to a more disciplined regulatory environment, success is increasingly determined by preparation, credibility, and choosing the right path to the public markets. While Q2 showed encouraging signs of progress, the data makes clear that thoughtful execution—not improving sentiment alone—continues to separate successful transactions from those that struggle to reach the finish line.

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].

In this episode of Inside the Emerging Growth Markets, Joseph Lucosky explores why uplistings have become one of the fastest-growing pathways to the public markets and why they may be the right strategy for many companies navigating today's increasingly selective listing environment.

As traditional IPOs continue to face greater scrutiny, companies and advisors are increasingly turning to alternative pathways, including uplistings, direct listings, cross listings, and reverse mergers. Joseph explains why a legitimate uplisting is not a shortcut or a lesser alternative, but rather a strategic path for established public companies that are ready to transition from the OTC markets to a senior exchange. He also discusses the practical realities of today's uplisting process, including trading requirements, reverse split mechanics, FINRA timelines, and the importance of choosing the right exchange and advisor team.

In this episode, Joseph covers:

• Why uplistings are gaining momentum in today's market
• The difference between organic and financing-based uplistings
• How Nasdaq and NYSE evaluate uplisting candidates differently
• Why FINRA timing and reverse split planning are critical to execution
• What separates successful uplisting transactions from those that stall

As the public markets continue to evolve, alternative pathways are becoming an increasingly important part of the capital formation ecosystem. For the right company, an uplisting is no longer simply an alternative to an IPO, it may be the most effective path to reaching a senior exchange. Success, however, depends on careful planning, credible execution, and understanding how today's regulatory and listing environment actually operates.

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].

In this episode of Inside the Emerging Growth Markets, Joseph Lucosky breaks down one of the biggest misconceptions currently shaping the microcap and emerging growth markets: the belief that Nasdaq and the New York Stock Exchange still operate the way they did just a few years ago.

For years, Nasdaq was viewed as the more formulaic and accessible exchange for emerging growth companies, while NYSE was seen as more selective and judgment-driven. But as both exchanges continue tightening standards and increasing scrutiny across the listing process, that gap is rapidly narrowing.

Joseph explains why the old “default Nasdaq” mindset no longer works in today’s market and why exchange selection has become a far more strategic decision tied to fit, probability of success, and how a company is likely to be evaluated throughout the process.

In this episode, Joseph covers:

• Why the old perception of Nasdaq vs. NYSE no longer fully applies
• How Nasdaq’s new discretionary environment changed the listing process
• Why the gap between the exchanges is closing on standards, but not process
• How exchange choice now impacts probability of success and deal strategy
• Why pathway analysis and advisor quality matter more than ever in today’s market

As both exchanges continue raising the bar, exchange selection is no longer simply about prestige, familiarity, or historical assumptions. Companies entering the public markets in 2026 are operating in a far more selective environment where structure, positioning, advisor quality, and execution strategy all play a significant role in determining whether a deal ultimately gets through the process.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected]

In this episode of Inside the Emerging Growth Markets, Joseph Lucosky examines one of the most controversial proposals currently facing the microcap market: Nasdaq’s proposed $5 million market capitalization delisting rule and the growing pushback it is generating across the public company ecosystem.

What may appear to be a straightforward effort to improve market quality has quickly evolved into a much larger debate about capital formation, investor protection, and whether current market structure policies align with Washington’s stated goal of helping more companies access and remain in the public markets. Drawing from recent meetings on Capitol Hill, Joseph discusses why this issue has become more than just a Nasdaq rule filing and what it could mean for emerging growth companies moving forward.

In this episode, Joseph covers:

• What Nasdaq’s proposed $5 million market cap rule would actually do
• Why critics believe the proposal creates an automatic delisting cliff
• How the rule could impact emerging growth and innovation companies
• The potential effects on capital raising, liquidity, and investor confidence
• Why the proposal is attracting attention from policymakers in Washington

As regulators, exchanges, and lawmakers continue debating the future of the public markets, the outcome of this proposal could have significant implications for smaller public companies and the broader emerging growth ecosystem. For founders, boards, investors, and advisors, understanding the stakes has never been more important.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected]

In Episode 2 of Inside the Emerging Growth Markets, Joseph Lucosky breaks down the real story behind Q1 2026 and why the microcap market isn’t disappearing, it’s evolving.

While traditional microcap IPO activity dropped dramatically year over year, the broader market tells a much different story. As exchanges continue tightening standards and increasing discretionary review, founders, bankers, and advisors are increasingly turning toward alternative pathways like uplistings, cross listings, and direct listings.

Joseph explains how the market has moved from a volume-driven environment to a far more selective and strategic one, where structure, positioning, and pathway analysis now matter more than ever.

In this episode, Joseph covers:

• Why Q1 2026 was not simply a “slower” market
• The dramatic decline in traditional microcap IPO volume and what caused it
• How Nasdaq and NYSE rule changes reshaped the landscape
• Why uplistings, cross listings, and direct listings surged in activity
• The growing importance of pathway analysis for founders and advisors
• How foreign private issuers are adapting to the new environment
• Why bigger deals are increasingly favored in today’s market
• What founders, boards, bankers, and consultants should be doing differently right now

Traditional IPO volume may have declined, but activity across alternative pathways accelerated as the market adapted to a more selective and strategic environment. Companies approaching the public markets in 2026 are facing a very different landscape than they were even a year ago, one where structure, positioning, and execution strategy play a far greater role in determining which deals move forward.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at [email protected].